Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-19-018412

Chief Financial Officer bought 94,500 shares at an average $1.22 ($114,968)

From the SEC's structured data for this filing

Trades in this filing

Kucinski Keith A · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-11-22 Purchase : show line 1 in the form +36,500 $1.20 $43,807 36,500 D
2019-11-25 Purchase : show line 2 in the form +58,000 $1.23 $71,160 94,500 D
Open-market purchases · 94,500 sh · avg $1.22 · $114,968
Loading xslF345X03/ownership.xml…